Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc. Earnings Recaps

VREOF Health Care 1 recap
Q1 2026 May 13, 2026

Vireo Growth’s shares rose modestly by 0.8% following Q1 results which showed steady pro forma revenue growth and margin improvements, but market reaction suggests investors are waiting for more decisive progress on integration and operational execution before rewarding the stock more fully.

Key takeaways
  • Reported GAAP revenue surged 333% year-over-year to $106.2 million, driven by multiple acquisitions closed in recent months.
  • Pro forma revenue, which includes all acquisitions as if they occurred on January 1, 2026, grew 5% year-over-year to $210.2 million, reflecting moderate organic growth in integrated markets.
  • Adjusted EBITDA on a pro forma basis increased 29.8% to $42.2 million, with margin expansion to 20.1% of sales from 16.2% last year.
  • Gross margin, excluding non-cash inventory fair value adjustments, improved by 280 basis points to 56.3%.
  • Company ended Q1 with a strong cash position of $137.8 million and $240 million in current assets versus $82 million in current liabilities, supporting ongoing M&A and investment plans.